Literature DB >> 6301713

Antibodies to large glycopeptides in sera from patients with ovarian germ cell tumours.

M Kawata, K Higaki, S Sekiya, H Takamizawa, T Muramatsu, K Okumura.   

Abstract

Antibodies reactive with a murine teratocarcinoma cell line (F9) were detected by immunofluorescence staining in sera from patients bearing ovarian germ cell tumour. Immunochemical studies revealed that antibodies binding to the cell surface of F9 cells react with large glycopeptides which are known to be components of F9 antigens defined by murine anti-F9 antibodies. In addition, treatment of F9 cells with retinoic acid, which induces differentiation of embryonal carcinoma cells, distinctly reduced both the ability of these antibodies to stain F9 cells and the biosynthesis of large glycopeptides by the cells. These findings indicate that the large glycopeptides precipitable by the patients' antibodies are differentiation associated antigens on characteristic embryonic cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301713      PMCID: PMC1536897     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Surface galactosyl glycopeptides of embryonal carcinoma cells.

Authors:  A Prujansky-Jacobovits; G Gachelin; T Muramatsu; N Sharon; F Jacob
Journal:  Biochem Biophys Res Commun       Date:  1979-07-27       Impact factor: 3.575

2.  Human and mouse embryonal carcinoma cells in culture share an embryonic antigen (F9).

Authors:  S Holden; O Bernard; K Artzt; W F Whitmore; D Bennett
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

3.  Decreased synthesis of large fucosyl glycopeptides during differentiation of embryonal carcinoma cells induced by retinoic acid and dibutyryl cyclic AMP.

Authors:  H Muramatsu; T Muramatsu
Journal:  Dev Biol       Date:  1982-04       Impact factor: 3.582

4.  Isolation of a human teratoma cell line which expresses F9 antigen.

Authors:  B Hogan; M Fellous; P Avner; F Jacob
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

5.  Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1).

Authors:  D Solter; B B Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

6.  Characterization of glycopeptides isolated from membranes of F9 embryonal carcinoma cells.

Authors:  T Muramatsu; G Gachelin; F Jacob
Journal:  Biochim Biophys Acta       Date:  1979-10-18

7.  Changes in fucosyl-glycopeptides during early post-implantation embryogenesis in the mouse.

Authors:  T Muramatsu; H Condamine; G Gachelin; F Jacob
Journal:  J Embryol Exp Morphol       Date:  1980-06

8.  Carbohydrate structure and cell differentitation: unique properties of fucosyl-glycopeptides isolated from embryonal carcinoma cells.

Authors:  T Muramatsu; G Gachelin; J F Nicolas; H Condamine; H Jakob; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

9.  Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cells.

Authors:  P L Stern; K R Willison; E Lennox; G Galfrè; C Milstein; D Secher; A Ziegler
Journal:  Cell       Date:  1978-08       Impact factor: 41.582

10.  Characterization of a human ovarian teratocarcinoma-derived cell line.

Authors:  J Zeuthen; J O Nørgaard; P Avner; M Fellous; J Wartiovaara; A Vaheri; A Rosén; B C Giovanella
Journal:  Int J Cancer       Date:  1980-01-15       Impact factor: 7.396

View more
  1 in total

Review 1.  Embryoglycan: a highly branched poly-N-acetyllactosamine in pluripotent stem cells and early embryonic cells.

Authors:  Takashi Muramatsu
Journal:  Glycoconj J       Date:  2016-05-17       Impact factor: 2.916

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.